Clinical Trial Detail

NCT ID NCT01637090
Title Everolimus in Treating Cutaneous T-cell Lymphoma
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements no
Sponsors Boston Medical Center
Indications

cutaneous T cell lymphoma

Therapies

Everolimus

Age Groups: adult

No variant requirements are available.